This page lists all pharmaceutical reports related to the field of Pain. The reports include market research reports and pipeline analyses.
Displaying 101 - 108 of 108 results
- Top R&D Drug Failures - Toxicity and Serious Adverse Events in Late Stage Drug Development are the Major Causes of Drug Failure
- Comparative Analysis of Late Stage Pipeline Molecules in Major Indications - Oncology Pipeline Leads with Most Promising Molecules in Late Stage Development
- Preclinical Models - Preclinical CROs will Continue to Improve the Quality and Accuracy of Data for Targeted Therapies
- Biomarkers in Drug Discovery - Earlier Usage of Biomarkers in Optimization Stage to Reduce Drug Attrition Rate Significantly
- GPCRs in Drug Discovery - Efforts to De-Orphanize Novel GPCR Targets are Increasing
- Neurology Devices Market to 2017 - High Potential for Usage of Neurostimulation Devices in Multiple Neurological Disorders to Drive Market Growth
- Neuropathic Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Irritable Bowel Syndrome (IBS) Therapeutics - Pipeline Assessment and Market Forecasts to 2018